Citigroup’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $6.98K | Buy |
+11,761
| New | +$6.76K | ﹤0.01% | 5286 |
|
|
2026
Q1 | – | Sell |
-1
| Closed | -$1 | – | 6481 |
|
|
2025
Q4 | $1 | Sell |
1
-3,527
| -100% | -$7.84K | ﹤0.01% | 6000 |
|
|
2025
Q3 | $6.53K | Buy |
3,528
+3,468
| +5,780% | +$5.65K | ﹤0.01% | 5150 |
|
|
2025
Q2 | $89 | Buy |
+60
| New | +$96 | ﹤0.01% | 5520 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | – | – | 6398 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | +$169 | ﹤0.01% | 6740 |
|
|
2020
Q1 | – | Sell |
-40
| Closed | -$6K | – | 7798 |
|
|
2019
Q4 | $6K | Buy |
+40
| New | +$7.47K | ﹤0.01% | 7363 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7843 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7875 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7841 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7859 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7885 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7763 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7695 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7673 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7165 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7218 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7116 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7138 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6884 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$56.2K | – | 6691 |
|
|
2016
Q1 | $73K | Sell |
2
-1
| -33% | -$31.7K | ﹤0.01% | 5888 |
|
|
2015
Q4 | $134K | Hold |
3
| – | – | ﹤0.01% | 5098 |
|
|
2015
Q3 | $201K | Buy |
3
+1
| +50% | +$107K | ﹤0.01% | 4486 |
|
|
2015
Q2 | $324K | Hold |
2
| – | – | ﹤0.01% | 4074 |
|
|
2015
Q1 | $326K | Hold |
2
| – | – | ﹤0.01% | 4118 |
|
|
2014
Q4 | $348K | Hold |
2
| – | – | ﹤0.01% | 4219 |
|
|
2014
Q3 | $450K | Buy |
2
+1
| +100% | +$285K | ﹤0.01% | 3613 |
|
|
2014
Q2 | $454K | Hold |
1
| – | – | ﹤0.01% | 3527 |
|
|
2014
Q1 | $273K | Buy |
+1
| New | +$602K | ﹤0.01% | 4035 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4855 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4518 |
|
Other funds holding TRAW
Citigroup's TRAW Position: Q3 2026 in Review
Citigroup opened a new position in Traws Pharma (TRAW) in Q3 2026: 11,761 shares worth $6.98K. The stake represents ﹤0.01% of the portfolio and ranks #5286 among its holdings. This is a return to the name: Citigroup previously reported a position in TRAW as recently as Q4 2025.
Citigroup first reported a position in TRAW in Q1 2014 and has held it in 15 quarters since. The position peaked at $454K in Q2 2014. 10 funds tracked by Wall St. Rank hold TRAW as of Q3 2026.
- Citigroup held 11,761 shares of Traws Pharma worth $6.98K as of Q3 2026.
- Traws Pharma was a new Citigroup position in Q3 2026.
- Traws Pharma made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5286 holding.
- Citigroup first reported a position in Traws Pharma in Q1 2014 and has held it in 15 quarters since.
- Citigroup's Traws Pharma position peaked at $454K in Q2 2014.
- 10 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.